Skip to search.
 FTSE 100 Up 0.08%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
396.22 Up 2.68(0.68%) 27 May 21:00
|After Hours: : 396.22 0.00 (0.00%) 27 May 22:11
Prev Close:393.54
Open:395.39
Bid:389.00 x 200
Ask:414.00 x 100
1y Target Est:473.48
Beta:1.50334
Earnings Date:2 Aug - 8 Aug (Est.)
Day's Range:389.62 - 398.49
52wk Range:348.96 - 605.93
Volume:548,059
Avg Vol (3m):969,380
Market Cap:41.42b
P/E (ttm):62.82
EPS (ttm):6.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 0.68%41.42b
AMGNUp 0.77%117.75b

Key Statistics

Forward P/E (1 yr):24.95
P/S (ttm):9.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :10.98
Quarterly EPS Est (Jun-16) :2.65
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.90

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback